Atlas Trials

Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer

Clinical trial NCT04752865 · UNKNOWN

Trial details

NCT number
NCT04752865
Sponsor
Hellenic Cooperative Oncology Group
Status
UNKNOWN
Study type
OBSERVATIONAL
Ovarian Cancer
Start date
2018-02-09
Primary completion
2023-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.